QLT Appoints Dr. Geoffrey F. Cox as Interim Chief Executive Officer
October 24, 2014 07:00 ET
|
QLT Inc.
VANCOUVER, British Columbia, Oct. 24, 2014 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today announced that current QLT Board member, Geoffrey F. Cox, Ph.D., has been...
QLT Announces Merger With Auxilium Pharmaceuticals, Inc. Terminates for Superior Proposal
October 09, 2014 06:47 ET
|
QLT Inc.
VANCOUVER, British Columbia, Oct. 9, 2014 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") announces that it has been advised by Auxilium Pharmaceuticals, Inc....
QLT Provides Further Update on Merger With Auxilium Pharmaceuticals, Inc.
September 22, 2014 07:07 ET
|
QLT Inc.
VANCOUVER, British Columbia, Sept. 22, 2014 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") announces that it has been advised by Auxilium Pharmaceuticals, Inc....
QLT Provides Update on Merger With Auxilium Pharmaceuticals, Inc.
September 17, 2014 07:05 ET
|
QLT Inc.
VANCOUVER, British Columbia, Sept. 17, 2014 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") announces that it has been advised by Auxilium Pharmaceuticals, Inc....
QLT Announces Positive Final Results From Phase 1b Retreatment Trial With Oral Synthetic cis-Retinoid (QLT091001) in Subjects With LCA or RP Due to Mutations in RPE65 or LRAT
September 12, 2014 07:00 ET
|
QLT Inc.
VANCOUVER, B.C., Sept. 12, 2014 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today announced positive final results from its international, multi-center, Phase 1b...
QLT Announces Adoption of Advance Notice Policy
August 07, 2014 07:00 ET
|
QLT Inc.
VANCOUVER, British Columbia, Aug. 7, 2014 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") announces the approval by its board of directors of an advance notice policy...
QLT Announces Second Quarter 2014 Results
August 05, 2014 07:00 ET
|
QLT Inc.
VANCOUVER, British Columbia, Aug. 5, 2014 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") is a biotechnology company dedicated to the development and commercialization of...
QLT Announces Publication in The Lancet of Phase 1b Data for QLT091001 in Leber Congenital Amaurosis Due to LRAT or RPE65 Mutations
July 14, 2014 07:00 ET
|
QLT Inc.
VANCOUVER, British Columbia, July 14, 2014 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today announced the publication of data from its Phase 1b proof-of-concept...
QLT Announces First Quarter 2014 Results
April 30, 2014 07:00 ET
|
QLT Inc.
VANCOUVER, British Columbia, April 30, 2014 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") is a biotechnology company dedicated to the development and...
QLT Announces Fourth Quarter and Year End 2013 Results
February 28, 2014 07:00 ET
|
QLT Inc.
VANCOUVER, British Columbia, Feb. 28, 2014 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") is a biotechnology company dedicated to the development and commercialization...